COMMUNIQUÉ DE PRESSE publié le 02/10/2026 à 14:27, il y a 1 mois 2 jours Form 8.3 - The Vanguard Group, Inc.: Rotork plc The Vanguard Group, Inc. discloses 5.47% interest in Rotork plc with 44,722,663 securities held. Sale of 3,380 securities at 4.89 GBP per unit Securities Disclosure The Vanguard Group Sale Rotork Plc
COMMUNIQUÉ DE PRESSE publié le 02/10/2026 à 14:27, il y a 1 mois 2 jours Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc The Vanguard Group, Inc. discloses 4.80% stake in Tate & Lyle plc through Form 8.3 filing as of 01 October 2026 Securities Form 8.3 Disclosure Vanguard Group Tate & Lyle Plc
COMMUNIQUÉ DE PRESSE publié le 02/10/2026 à 14:26, il y a 1 mois 2 jours Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses 3.59% ownership in Spire Healthcare Group plc. Sale of 1,078 1p ordinary securities at 2.48 GBP per unit Securities Vanguard Group Ownership Disclosure Spire Healthcare Sale
COMMUNIQUÉ DE PRESSE publié le 02/10/2026 à 14:24, il y a 1 mois 2 jours Form 8.3 - The Vanguard Group, Inc.: SEGRO plc The Vanguard Group, Inc. discloses 5.64% stake in SEGRO plc's ordinary shares as of October 1, 2026, with recent purchase of 4,137 shares at 9.13 GBP each Ordinary Shares The Vanguard Group Share Purchase Stake Disclosure SEGRO PLC
COMMUNIQUÉ DE PRESSE publié le 02/10/2026 à 14:24, il y a 1 mois 2 jours Form 8.3 - The Vanguard Group, Inc.: Bodycote plc The Vanguard Group, Inc. discloses a 5.47% interest in Bodycote plc through relevant securities. Dealings include the sale of 704 securities at 9.14 GBP per unit The Vanguard Group Financial Disclosure Securities Dealing Interest Disclosure Bodycote PLC
BRÈVE publiée le 01/10/2026 à 14:59, il y a 1 mois 3 jours The Vanguard Group, Inc. Discloses Major Position in Prologis, Inc. Form 8.3 The Vanguard Group Securities Disclosure Shareholding Prologis, Inc.
BRÈVE publiée le 01/10/2026 à 14:59, il y a 1 mois 3 jours Le groupe Vanguard révèle une participation importante dans Prologis, Inc. Actionnariat Le Groupe Vanguard Formulaire 8.3 Informations Sur Les Valeurs Mobilières Prologis, Inc.
BRÈVE publiée le 01/10/2026 à 14:59, il y a 1 mois 3 jours The Vanguard Group Discloses Position in RHI Magnesita N.V. Form 8.3 Takeover Code Securities Disclosure Vanguard Group RHI Magnesita
BRÈVE publiée le 01/10/2026 à 14:59, il y a 1 mois 3 jours Le groupe Vanguard révèle sa position dans RHI Magnesita NV Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Information Sur Les Valeurs Mobilières Magnésium RHI
BRÈVE publiée le 01/10/2026 à 14:58, il y a 1 mois 3 jours The Vanguard Group's Disclosure on Permanent TSB Group Holdings Ordinary Shares The Vanguard Group Form 8.3 Filing Irish Takeover Permanent TSB
Publié le 04/11/2026 à 18:00, il y a 8 heures 38 minutes The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Publié le 04/11/2026 à 18:00, il y a 8 heures 38 minutes L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Publié le 04/11/2026 à 17:44, il y a 8 heures 54 minutes Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
Publié le 04/11/2026 à 23:10, il y a 3 heures 28 minutes Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Publié le 04/11/2026 à 23:00, il y a 3 heures 38 minutes Viemed Healthcare Announces Third Quarter 2026 Financial Results
Publié le 04/11/2026 à 22:15, il y a 4 heures 23 minutes Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Publié le 04/11/2026 à 22:05, il y a 4 heures 33 minutes Stabilis Solutions Announces Third Quarter 2026 Results
Publié le 05/11/2026 à 00:02, il y a 2 heures 36 minutes EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Publié le 04/11/2026 à 19:41, il y a 6 heures 57 minutes EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Publié le 04/11/2026 à 19:25, il y a 7 heures 13 minutes Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Publié le 04/11/2026 à 18:43, il y a 7 heures 55 minutes EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
Publié le 04/11/2026 à 18:05, il y a 8 heures 33 minutes Redis Expands Redis Iris to Give AI Agents the Memory, Context, and Messaging They Need to get to Production
